Physician profile
Roberto Lucca
NPI 1588690770
$3,542.61
in general payments reported to CMS, 2019-2025
10 companies · $1,182 in 2025
The $1,182 reported for 2025 was more than what 93% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $835 · 2020: $17.24 · 2021: $262 · 2022: $226 · 2023: $198 · 2024: $821 · 2025: $1,182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,202.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,202.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $624.70 | 2019 | |
| Lumenis Be INC | $610.63 | 2025 | Optilight |
| Alcon Vision LLC | $557.13 | 2019-2024 | Precision 1 |
| Glaukos Corporation | $537.37 | 2023-2025 | Radius |
| Coopervision INC. | $366.84 | 2021-2025 | Onefit Contact Lens, Misight Contact Lens, Myday Contact Lens |
| Bausch & Lomb Americas INC. | $328.27 | 2024-2025 | Vyzulta, Miebo, Lotemax |
| Johnson & Johnson Vision Care, INC. | $272.15 | 2024-2025 | Acuvue |
| Regeneron Healthcare Solutions, INC. | $119.85 | 2021 | |
| Sight Sciences, INC. | $108.43 | 2022 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roberto Lucca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.